Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2026-01-07 @ 6:50 AM
Study NCT ID:
NCT00135395
Status:
COMPLETED
Last Update Posted:
2010-02-05
First Post:
2005-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-05
Start Date Type:
None
Primary Completion Date:
2006-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-25
First Submit QC Date:
None
Study First Post Date:
2005-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2010-02-03
Last Update Post Date:
2010-02-05
Last Update Post Date Type:
ESTIMATED